ACADIA Pharmaceuticals (NASDAQ:ACAD) CEO Uli Hacksell sold 25,000 shares of ACADIA Pharmaceuticals stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $17.75, for a total value of $443,750.00. ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD) shares after opening at $0.83 on last trade day and at the end of the day closed at $19.44. Company price to sales ratio in past twelve months was calculated as 1740.06 and price to cash ratio as 10.30. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)showed a negative weekly performance of -2.99%.
Sangamo Biosciences (NASDAQ:SGMO) CEO Edward Lanphier II sold 25,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $14.20, for a total transaction of $355,000.00. Following the transaction, the chief executive officer now directly owns 295,000 shares of the company’s stock, valued at approximately $4,189,000. Sangamo Biosciences, Inc. (NASDAQ:SGMO) shares fell-1.89% in last trading session and ended the day on $13.99.SGMO return on equity ratio is recorded as -28.90% and its return on assets is -24.70%. Sangamo Biosciences, Inc. (NASDAQ:SGMO) yearly performance is 46.95%.
XOMA Corp (NASDAQ:XOMA) CEO John Varian sold 10,000 shares of XOMA Corp stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $4.06, for a total value of $40,600.00. Following the transaction, the chief executive officer now directly owns 285,613 shares in the company, valued at approximately $1,159,589. XOMA Corp (NASDAQ:XOMA) shares moved down-2.55% in last trading session and was closed at $4.21, while trading in range of $4.19 – $4.42. XOMA Corp (NASDAQ:XOMA) year to date (YTD) performance is-37.44%.
Lifelock (NASDAQ:LOCK) CFO Chris G. Power sold 4,000 shares of the company’s stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $15.71, for a total value of $62,840.00. Following the completion of the sale, the chief financial officer now directly owns 23,333 shares of the company’s stock, valued at approximately $366,561. Lifelock Inc (NYSE:LOCK)weekly performance is 2.63%. On last trading day company shares ended up $15.99. Lifelock Inc (NYSE:LOCK) distance from 50-day simple moving average (SMA50) is -17.08%. Analysts mean target price for the company is $25.63.